ZA872964B - Remote administration of hyaluronic acid to mammals - Google Patents

Remote administration of hyaluronic acid to mammals

Info

Publication number
ZA872964B
ZA872964B ZA872964A ZA872964A ZA872964B ZA 872964 B ZA872964 B ZA 872964B ZA 872964 A ZA872964 A ZA 872964A ZA 872964 A ZA872964 A ZA 872964A ZA 872964 B ZA872964 B ZA 872964B
Authority
ZA
South Africa
Prior art keywords
hyaluronic acid
tissue
traumatized tissue
mammals
remote administration
Prior art date
Application number
ZA872964A
Other languages
English (en)
Inventor
H. Schultz Richard
S. Wollen Terry
D. Greene Nathan
K. Brown Karen
O. Mozier John
Original Assignee
Mobay Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mobay Corporation filed Critical Mobay Corporation
Publication of ZA872964B publication Critical patent/ZA872964B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA872964A 1986-04-28 1987-04-27 Remote administration of hyaluronic acid to mammals ZA872964B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/856,732 US4808576A (en) 1986-04-28 1986-04-28 Remote administration of hyaluronic acid to mammals

Publications (1)

Publication Number Publication Date
ZA872964B true ZA872964B (en) 1987-10-20

Family

ID=25324378

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA872964A ZA872964B (en) 1986-04-28 1987-04-27 Remote administration of hyaluronic acid to mammals

Country Status (13)

Country Link
US (1) US4808576A (ja)
EP (1) EP0243867B1 (ja)
JP (1) JP2567393B2 (ja)
KR (1) KR950007233B1 (ja)
AT (1) ATE61523T1 (ja)
AU (1) AU596838B2 (ja)
CA (1) CA1314218C (ja)
DE (1) DE3768546D1 (ja)
DK (1) DK212587A (ja)
ES (1) ES2038135T3 (ja)
HU (1) HUT43790A (ja)
NZ (1) NZ220098A (ja)
ZA (1) ZA872964B (ja)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468737A (en) * 1982-05-07 1995-11-21 Carrington Laboratories, Inc. Wound healing accelerated by systemic administration of polysaccharide from aloe
US5080893A (en) * 1988-05-31 1992-01-14 University Of Florida Method for preventing surgical adhesions using a dilute solution of polymer
US6010692A (en) * 1988-05-31 2000-01-04 University Of Florida Research Foundation, Inc. Method and composition for preventing surgical adhesions and tissue damage
US5140016A (en) * 1988-05-31 1992-08-18 University Of Florida Method and composition for preventing surgical adhesions using a dilute solution of polymer
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
US5095037B1 (en) * 1989-12-21 1995-12-19 Nissho Kk Combined anti-inflammatory agent
US5102783A (en) * 1990-01-12 1992-04-07 Vetrepharm, Inc. Composition and method for culturing and freezing cells and tissues
IT1240316B (it) * 1990-02-21 1993-12-07 Ricerca Di Schiena Del Dr. Michele G. Di Schiema & C. Composizioni a base di acido ialuronico ad alto peso molecolare somministrabili per via topica per il trattamento di infiammazioni del cavo orale ,per la cosmetica e l'igiene del cavo orale
US5824658A (en) * 1990-09-18 1998-10-20 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5910489A (en) * 1990-09-18 1999-06-08 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5990096A (en) * 1990-09-18 1999-11-23 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
CA2061703C (en) * 1992-02-20 2002-07-02 Rudolf E. Falk Formulations containing hyaluronic acid
US5639738A (en) * 1992-02-20 1997-06-17 Hyal Pharmaceutical Corporation Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
WO1992006714A1 (en) * 1990-10-18 1992-04-30 Shiseido Co., Ltd. Combination of hyaluronic acid with medicinal ingredient and production thereof
US5733891A (en) * 1990-10-18 1998-03-31 Shiseido Co., Ltd. Compound for medicinal ingredient and hyaluronic acid and process for producing the same
US5234914A (en) * 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
US5834444A (en) * 1991-07-03 1998-11-10 Hyal Pharmaceutical Corporation Hyaluronic acid and salts thereof inhibit arterial restenosis
US5792753A (en) * 1991-07-03 1998-08-11 Hyal Pharmaceutical Corporation Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
US6103704A (en) * 1991-07-03 2000-08-15 Hyal Pharmaceutical Corporation Therapeutic methods using hyaluronic acid
US5977088A (en) * 1991-07-03 1999-11-02 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
JP3310994B2 (ja) * 1991-07-03 2002-08-05 電気化学工業株式会社 アレルギー治療剤
US6022866A (en) * 1991-07-03 2000-02-08 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
US5817644A (en) * 1991-07-03 1998-10-06 Hyal Pharmaceutical Corporation Targeting of dosages of medicine and therapeutic agents
WO1994007505A1 (en) * 1991-07-03 1994-04-14 Norpharmco Inc. Use of hyaluronic acid and forms to prevent arterial restenosis
US5990095A (en) * 1991-07-03 1999-11-23 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
CA2061567C (en) * 1992-02-20 1998-02-03 Rudolf E. Falk Use of hyaluronic acid to repair ischemia reperfusion damage
US6218373B1 (en) 1992-02-20 2001-04-17 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5942498A (en) * 1992-02-20 1999-08-24 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US6114314A (en) * 1992-02-21 2000-09-05 Hyal Pharmaceutical Corp. Formulations containing hyaluronic acid
US5767106A (en) * 1992-02-21 1998-06-16 Hyal Pharmaceutical Corporation Treatment of disease and conditions associated with macrophage infiltration
US5888984A (en) * 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
US6096728A (en) * 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
US20050090662A1 (en) * 1997-01-15 2005-04-28 Beavers Ellington M. Method of making free acids from polysaccharide salts
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
DK1083929T3 (da) * 1998-06-05 2007-06-11 Nutramax Lab Inc Anvendelse af anabolske stoffer
JP4607264B2 (ja) * 1998-12-01 2011-01-05 生化学工業株式会社 ヒアルロン酸を有効成分とする異所性石灰化抑制剤
CA2361268C (en) 1999-02-01 2014-06-10 Dermal Research Laboratories, Inc. A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
WO2000059490A2 (en) * 1999-04-06 2000-10-12 Genzyme Corporation Immunomodulating composition for use especially in the treatment of inflammations, infections and surgical adhesions
US7879824B2 (en) 2001-07-31 2011-02-01 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
NZ524076A (en) * 2000-07-31 2004-07-30 Dermal Res Lab Inc Preventing or treating diseases associated with allergies, autoimmunity and adhesion, metastatic and coronary cascades using complex carbohydrates, in particular hyaluronic acid
DE10053053A1 (de) * 2000-10-19 2002-05-16 Knoell Hans Forschung Ev Pharmazeutische Formulierungen zur Hemmung von entzündlichen Arthritiden
DE10111165A1 (de) * 2001-03-02 2002-10-10 Knoell Hans Forschung Ev Verwendung von Hyaluronsäure-Uroniden zur Behandlung von entzündlichen Vorgängen
US6607745B2 (en) 2001-05-18 2003-08-19 Harry Leneau Ingestion of hyaluronic acid for improved joint function and health
US7635489B2 (en) * 2001-05-18 2009-12-22 Leneau Holdings, Llc Ingestion of hyaluronic acid for improved joint health
US6528076B2 (en) 2001-07-06 2003-03-04 Magic Herb Corp. Topical compositions and methods for treating pain
KR20030026384A (ko) * 2001-09-12 2003-04-03 정옥조 당뇨병 환자용 건강식품의 제조방법 및 그 제품
WO2003070256A1 (en) * 2002-02-15 2003-08-28 Research Development Foundation Hyaluronic acid mediated adenoviral transduction
US20050142208A1 (en) * 2002-05-09 2005-06-30 Won Min Yoo Pharmceutical composition for treatment of wounds conntaining blood plasma or serum
JP2004135177A (ja) * 2002-10-11 2004-04-30 Sharp Corp 携帯電話機
ES2374157T3 (es) 2002-10-16 2012-02-14 Arthrodynamic Technologies, Animal Health Division, Inc. Tratamiento para la sinovitis traumática y el cartílago articular dañado.
US20080003258A1 (en) * 2002-10-16 2008-01-03 Marcum Frank D Composition and Method for Treating Rheumatoid Arthritis
US8455458B2 (en) 2002-10-16 2013-06-04 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treating connective tissue damage
US7485629B2 (en) * 2002-10-16 2009-02-03 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treatment of joint damage
US7504387B2 (en) * 2002-10-16 2009-03-17 Arthrodynamic Technologies, Animal Health Division, Inc. Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis
US7803787B2 (en) * 2002-10-16 2010-09-28 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treating connective tissue damage by transmucosal administration
PL1677806T3 (pl) * 2003-10-09 2009-05-29 2405871 Ontario Inc Sposoby leczenia ostrego i nadmiernego skręcenia i naciągnięcia przy użyciu kwasu hialuronowego
GB0411165D0 (en) * 2004-05-19 2004-06-23 Bionovate Ltd Hyaluronic acid containing pharmaceutical or veterinary compounds
CA2475762A1 (en) * 2004-07-27 2006-01-27 Rycor Technology Investments Corp. Dose dependent elimination of ha and cell receptor stimulation
ES2537751T3 (es) * 2004-12-30 2015-06-11 Genzyme Corporation Regímenes para viscosuplementación intraarticular
US7323184B2 (en) * 2005-08-22 2008-01-29 Healagenics, Inc. Compositions and methods for the treatment of wounds and the reduction of scar formation
US9492381B1 (en) 2005-11-10 2016-11-15 Reyn Pharma, Llc Method of administering hyaluronan formulation for preventing and ameliorating osteoarthritis
US8598144B1 (en) 2005-11-10 2013-12-03 Reyn Pharma, Llc Method of administering hyaluronan formulation for the amelioration of osteoarthritis
WO2007070547A2 (en) 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
CA2633978A1 (en) 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects
US20080102107A1 (en) * 2005-12-16 2008-05-01 Valex Pharmaceuticals, Llc Compositions and methods for transdermal joint pain therapy
ES2621876T3 (es) * 2006-09-13 2017-07-05 Enhance Skin Products Inc. Composición cosmética para el tratamiento de la piel y procedimientos de la misma
AU2008210557B2 (en) 2007-01-30 2013-08-01 Cypress Pharmaceutical, Inc. Hyaluronate compositions
US9186375B2 (en) 2007-06-21 2015-11-17 Arthrodynamic Technologies, Animal Health Division, Inc. Glycosaminoglycan compositions in combination with stem cells
US8178511B1 (en) * 2008-07-02 2012-05-15 Smith James D Method of administering hyaluronan formulation for the amelioration of osteopenia
CA2739243C (en) 2008-10-02 2017-08-22 L.R.R.& D. Ltd. Wound dressing comprising polymeric foam matrix and a hydrophilic polysaccharide disposed therein
EP2886104A1 (en) 2013-12-11 2015-06-24 Patir, Suleyman An intra-articular gel
KR102588734B1 (ko) * 2021-07-15 2023-10-13 최문석 짬뽕 감자 제조방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4055660A (en) * 1974-06-26 1977-10-25 Meierhenry Dwight W Treatment for warts
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
GB1523965A (en) * 1976-03-19 1978-09-06 Ici Ltd Pharmaceutical compositions containing steroids
US4296104A (en) * 1979-08-30 1981-10-20 Herschler R J Therapeutic dimethyl sulfoxide composition and methods of use
US4272522A (en) * 1979-10-15 1981-06-09 Balazs Endre A Method for stimulating phagocytic activity and synergistic compositions therefor
JPS56164120A (en) * 1980-05-22 1981-12-17 Chisso Corp Antitumor agent
IT1212892B (it) * 1983-10-11 1989-11-30 Della Valle Francesco Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica
US4517295A (en) * 1983-02-18 1985-05-14 Diagnostic, Inc. Hyaluronic acid from bacterial culture
NO161573C (no) * 1983-11-25 1989-08-30 Miles Inc Fremgangsmaate til fremstilling av hyaluronsyre.
NO160722C (no) * 1983-11-25 1989-05-24 Miles Inc Fremgangsmaate for fremstilling av ultraren hyaluronsyre.
US4716224A (en) * 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
JPS6120034A (ja) * 1984-07-06 1986-01-28 Konishiroku Photo Ind Co Ltd 写真乳剤の保管方法
SE8501723L (sv) * 1985-04-09 1986-10-10 Pharmacia Ab Preparation att anvendas vid behandling av ledinflammation
GB8509301D0 (en) * 1985-04-11 1985-05-15 Clinical Products Dev Ltd Device for surgical procedures

Also Published As

Publication number Publication date
KR950007233B1 (ko) 1995-07-07
ATE61523T1 (de) 1991-03-15
HUT43790A (en) 1987-12-28
EP0243867A2 (de) 1987-11-04
ES2038135T3 (es) 1996-07-16
AU596838B2 (en) 1990-05-17
US4808576A (en) 1989-02-28
DK212587D0 (da) 1987-04-27
JP2567393B2 (ja) 1996-12-25
JPS62255428A (ja) 1987-11-07
CA1314218C (en) 1993-03-09
AU7178287A (en) 1987-10-29
KR890001572A (ko) 1989-03-27
EP0243867B1 (de) 1991-03-13
EP0243867A3 (en) 1988-03-23
DE3768546D1 (de) 1991-04-18
NZ220098A (en) 1991-06-25
DK212587A (da) 1987-10-29

Similar Documents

Publication Publication Date Title
ZA872964B (en) Remote administration of hyaluronic acid to mammals
DE68910159D1 (de) Dosierform für Verabreichung in der Humanmedizin.
IL99699A0 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
HK1005985A1 (en) Combined use of hyaluronic acid and therapeutic agents to improve the therapeutic effect
MX163955B (es) Composicion farmaceutica de dihidrocodeina e ibuprofen
ZA883602B (en) Medicament
ES2010561A6 (es) Procedimiento para preparar una composicion farmaceutica a base de un analogo de somatostatina.
KR950702120A (ko) 골다공증 치료를 위한 포스포네이트의 용도(use of phosphonates for the treatment of osteoporosis)
SE8204873D0 (sv) Farmaceutiska preparat, innefattande humant insulin och human c-peptid
AU6932691A (en) Administration method of antithrombin
ES2121103T3 (es) Antagonistas de la angiotensina ii para el tratamiento de enfermedades viricas.
GR3017855T3 (en) Use of lithium in the treatment or prophylaxis of Molluscum contagiosum.
DE3851497D1 (de) 2,3-Dihydroergoline zur Steigerung serotonerger Funktionen.
LV11987A (lv) Aptaukosanas noversanas vai arstesanas metode
GR3018837T3 (en) Subcutaneous administration of human chorionic gonadotrophin.
GR3032156T3 (en) Treatment of human lactation failure.
SE8804640L (sv) Laekemedel omfattande cyklolinopeptide a
HK139796A (en) Use of stomatostatin in the manufacture of a medicament for the treatment of rheumatoid arthritis
EP0282690A3 (en) Treatment of rheumatoid arthritis with 3,5-dichloromethotrexate
AU4918900A (en) Interferon-beta use in the treatment of ewing's family of tumors
MD197G2 (ro) Preparat şi procedeu de tratare a hipogalactiei
EP0621789A4 (en) Pharmaceutical pentapeptide compositions and methods of use thereof.
GB2111505A (en) Endorphins having placental or pancreatic origin
UA10219A (uk) Спосіб лікування туберкульозу легень
HUT59597A (en) Process for producing pharmaceutical compositions contaiing pharmaceutically active tetrahydro-naphtalene derivatives